CDH1 and colorectal cancer: In particular, the 80 kDa soluble E-cadherin in tissue is largely resistant towards further proteolytic processing by endogenous proteases and significant levels of soluble E-cadherin were detected in serum in patients with late stage colorectal cancer [20].